Cauliflower-like warts/Condyloma Acuminatum (C

Genital Warts/Condyloma Acuminatum

SR-T100 Gel New Drug Development for Treating Genital Warts

The second-phase clinical trials have been completed in Taiwan and have been reported in the U.S. Data shows that the complete cure rate (complete response) for both men and women is over 80%, with minimal side effects, indicating great potential for successful development. The market for skin cancer in situ in Taiwan is relatively smaller than for genital warts. Therefore, the company plans to continue the third-phase clinical trial of SR-T100 Gel for treating genital warts once the SR-T100 injection clinical trials are on track, in order to complete the development of the SR-T100 topical gel new drug.